Boston Partners

Boston Partners’s Transmedics TMDX Stock Holding History

Boston Partners’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,553	Closed	-$300K	–	761
2022 Q2	$300K	Sell	9,553 -9,258	-49%	-$247K	﹤0.01%	651
2022 Q1	$507K	Buy	18,811 +2,251	+14%	+$40.3K	﹤0.01%	620
2021 Q4	$317K	Buy	+16,560	New	+$415K	﹤0.01%	642
2020 Q1	–	Sell	-10,675	Closed	-$203K	–	748
2019 Q4	$203K	Buy	10,675 +6,622	+163%	+$122K	﹤0.01%	641
2019 Q3	$96K	Buy	+4,053	New	+$97.2K	﹤0.01%	667

Other funds holding TMDX

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Macquarie Group

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Summit Partners Public Asset Management Boston, Massachusetts $2.16B AUM 162.29% 1-Year Est. Return

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Lord, Abbett & Co

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return